Acp Lantern Acquisition, Inc.
Records under this name other than patents Acp Lantern Acquisition, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Acp Lantern Acquisition, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,263,042 | Contrast Agents for Myocardial Perfusion Imaging merged into Bristol Myers Squibb Medical Imaging Inc. - now held by Lantheus Medical Imaging, Inc. In force · High confidence | In force | High confidence | |
| US 10,010,631 | Ligands for Imaging Cardiac Innervation merged into Bristol Myers Squibb Medical Imaging Inc. - now held by Lantheus Medical Imaging, Inc. In force · Medium confidence | In force | Medium confidence | |
| US 11,241,509 | Ligands for Imaging Cardiac Innervation merged into Bristol Myers Squibb Medical Imaging Inc. - now held by Lantheus Medical Imaging, Inc. In force · Medium confidence | In force | Medium confidence | |
| US 8,226,929 | Contrast Agents for Myocardial Perfusion Imaging merged into Bristol Myers Squibb Medical Imaging Inc. - now held by Lantheus Medical Imaging, Inc. In force · High confidence | In force | High confidence | |
| US 12,324,845 | Ligands for Imaging Cardiac Innervation merged into Bristol Myers Squibb Medical Imaging Inc. - now held by Lantheus Medical Imaging, Inc. In force · Low confidence | In force | Low confidence | |
| US 7,824,659 | Methods of Making Radiolabeled Tracers and Precursors Thereof now held by Lantheus Medical Imaging, Inc. In force · High confidence | In force | High confidence | |
| US 7,344,702 | Contrast Agents for Myocardial Perfusion Imaging now held by Bristol-Myers Squibb Pharma Company Term ended Term ended May 26, 2026 · High confidence | Term ended | Term ended May 26, 2026 | High confidence |
| US 7,485,283 | Contrast Agents for Myocardial Perfusion Imaging now held by Lantheus Medical Imaging, Inc. Term ended Ended no later than Mar 13, 2026 · Medium confidence | Term ended | Ended no later than Mar 13, 2026 | Medium confidence |
| US 9,161,997 | Contrast Agents for Myocardial Perfusion Imaging merged into Bristol Myers Squibb Medical Imaging Inc. - now held by Lantheus Medical Imaging, Inc. Term ended Ended no later than Feb 4, 2026 · Low confidence | Term ended | Ended no later than Feb 4, 2026 | Low confidence |
| US 9,718,786 | Contrast Agents for Myocardial Perfusion Imaging merged into Bristol Myers Squibb Medical Imaging Inc. - now held by Lantheus Medical Imaging, Inc. Term ended Ended no later than Feb 10, 2025 · Medium confidence | Term ended | Ended no later than Feb 10, 2025 | Medium confidence |